Evolution of traditional Chinese medicine registration review and approval policies: research based on the LDA topic model.

IF 3.4 3区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Frontiers in Public Health Pub Date : 2025-10-01 eCollection Date: 2025-01-01 DOI:10.3389/fpubh.2025.1655636
Kaidi Lu, Ming Xie, Wanping Sun, Yiming Liu
{"title":"Evolution of traditional Chinese medicine registration review and approval policies: research based on the LDA topic model.","authors":"Kaidi Lu, Ming Xie, Wanping Sun, Yiming Liu","doi":"10.3389/fpubh.2025.1655636","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The economic expansion of the Traditional Chinese Medicine (TCM) industry has prompted the Chinese government to introduce a series of policies focused on the registration review and approval of TCM. These policies aim to provide scientific and practical guidance for the innovation, protection, and progress of TCM. Although scholars have conducted detailed studies on the quantitative assessment of Traditional Chinese Medicine Registration Review and Approval Policies(TCMRAPs), Research on the evolution analysis of these policies is still relatively lacking.</p><p><strong>Methods: </strong>The evolution of TCMRAPs was analyzed using the Latent Dirichlet Allocation (LDA) topic model.</p><p><strong>Results: </strong>The results show that the scope of concern of the TCMRAPs in China is vast. TCMRAPs demonstrate their uniqueness at each stage, and over time, they have exhibited a development trend from a basic framework to standardization and refinement.</p><p><strong>Discussion: </strong>This study provides a reference for the subsequent formulation of TCMRAPs in China. Also, it offers an assessment method and theoretical reference for other countries in formulating their own policies for the drugs.</p>","PeriodicalId":12548,"journal":{"name":"Frontiers in Public Health","volume":"13 ","pages":"1655636"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521254/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fpubh.2025.1655636","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The economic expansion of the Traditional Chinese Medicine (TCM) industry has prompted the Chinese government to introduce a series of policies focused on the registration review and approval of TCM. These policies aim to provide scientific and practical guidance for the innovation, protection, and progress of TCM. Although scholars have conducted detailed studies on the quantitative assessment of Traditional Chinese Medicine Registration Review and Approval Policies(TCMRAPs), Research on the evolution analysis of these policies is still relatively lacking.

Methods: The evolution of TCMRAPs was analyzed using the Latent Dirichlet Allocation (LDA) topic model.

Results: The results show that the scope of concern of the TCMRAPs in China is vast. TCMRAPs demonstrate their uniqueness at each stage, and over time, they have exhibited a development trend from a basic framework to standardization and refinement.

Discussion: This study provides a reference for the subsequent formulation of TCMRAPs in China. Also, it offers an assessment method and theoretical reference for other countries in formulating their own policies for the drugs.

Abstract Image

Abstract Image

Abstract Image

中药注册审批政策演变:基于LDA主题模型的研究
导读:中药产业的经济扩张促使中国政府出台了一系列针对中药注册审批的政策。这些政策旨在为中医药的创新、保护和发展提供科学和实用的指导。虽然学者们对中药注册审批政策的定量评估进行了详细的研究,但对这些政策的演变分析研究仍然相对缺乏。方法:采用潜在狄利克雷分配(Latent Dirichlet Allocation, LDA)主题模型分析tcmrap的演化。结果:研究结果表明,中药mraps在中国的关注范围是广泛的。tcmrap在每个阶段都表现出其独特性,随着时间的推移,它们呈现出从基本框架到标准化和细化的发展趋势。讨论:本研究为中国后续中药制剂的制定提供参考。同时也为其他国家制定本国的药品政策提供了一种评价方法和理论参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Public Health
Frontiers in Public Health Medicine-Public Health, Environmental and Occupational Health
CiteScore
4.80
自引率
7.70%
发文量
4469
审稿时长
14 weeks
期刊介绍: Frontiers in Public Health is a multidisciplinary open-access journal which publishes rigorously peer-reviewed research and is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians, policy makers and the public worldwide. The journal aims at overcoming current fragmentation in research and publication, promoting consistency in pursuing relevant scientific themes, and supporting finding dissemination and translation into practice. Frontiers in Public Health is organized into Specialty Sections that cover different areas of research in the field. Please refer to the author guidelines for details on article types and the submission process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信